Records containing: HIV-1-infection
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-09-26Retrospective Review of DTG/3TC Versus BIC/F/TAF Across a Multi Clinic Infectious Disease Organization in Southeast United States (REVIVE Study)
-
CLINICAL_TRIALS study record update · 2025-09-16A Multi-center, Two-Part, Single-Arm, Open Label, 25-Week Trial With PRO 140 in Treatment-Experienced HIV-1 Subjects
-
CLINICAL_TRIALS study record update · 2025-09-11Investigating the Optimal Management of Dolutegravir Resistance: an Open-label Randomised Controlled Trial of Maintaining Dolutegravir or Switch to Ritonavir-boosted Darunavir
-
CLINICAL_TRIALS study record update · 2025-09-05Investigating the Optimal Management of Dolutegravir Resistance: a Multi-country Cohort Study
-
CLINICAL_TRIALS study record update · 2025-09-04A Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of Glycan-trimmed HIV-1 Nanoparticle Vaccine (UVAX-1107), Followed by Homologous or Wild-type HIV-1 Nanoparticle Vaccine (UVAX-1197) Boost, Each Adjuvanted With 3M-052-AF + Alum in Adult Participants Without HIV
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2025-09-03Fecal Microbiota Transplantation to Reduce Immune Activation in ART-treated People Living With HIV With Low CD4/CD8 Ratio: The Gutsy Study
-
CLINICAL_TRIALS study record update · 2025-09-02Testing the Efficacy and Mechanisms of an Adapted Resilience Building Intervention in People Aging With HIV
-
CLINICAL_TRIALS study record update · 2025-08-24IGHID 12107 - A Phase I Study to Evaluate the Safety and Immunogenicity of the ChAdOx1.HIVconsv62 - MVA.tHIVconsv4 (C62-M4) or, ChAdOx1.tHIVconsv1+C62 - MVA.tHIVconsv3+M4 (C1C62-M3M4) Prime-Boost Regimens in Persons With HIV-1 Suppressed on Antiretroviral Therapy
-
CLINICAL_TRIALS study record update · 2025-08-06Impact of Rapid ART Initiation on Retention in Care in the Southern US
-
CLINICAL_TRIALS study record update · 2025-08-03Changes in Immunologic Parameters Following the Addition of Fostemsavir in Virologically Suppressed Immunologic Non-responders Living With HIV-the RECOVER Study
-
CLINICAL_TRIALS study record update · 2025-07-31Phase I/II Study of the Pharmacokinetics and Safety of Long-Acting Injectable Cabotegravir and Rilpivirine in Pregnant and Postpartum Adults With HIV-1
-
CLINICAL_TRIALS study record update · 2025-07-30Dolutegravir-Lamivudine for naïve HIV-Infected Patients With ≤200 CD4/mm3
-
CLINICAL_TRIALS study record update · 2025-07-29Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV
-
CLINICAL_TRIALS study record update · 2025-07-24Addressing Barriers to Achieving Cardiometabolic Disorders Prevention and Treatment Goals for Persons Living With HIV in the Southeastern United States
-
CLINICAL_TRIALS study record update · 2025-07-23Research on the Psychological Status of Patients With HIV-1 Infection
-
CLINICAL_TRIALS study record update · 2025-07-23Immunotherapy With a JAK1/JAK2 Inhibitor (Baricitinib) and an mTORC1 Inhibitor (Sirolimus), Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption: a Phase II Multicenter, Multi-arm, Multi-stage, Randomized, Double-blind, Placebo-controlled, Adaptative Trial
-
CLINICAL_TRIALS study record update · 2025-07-23Effectiveness of Comprehensive Ending the Epidemic (ETE) Interventions in the Dental Setting
-
CLINICAL_TRIALS study record update · 2025-07-18DTG/3TC vs. BIC/FTC/TAF Maintenance Therapy in People Living With HIV: an Open-label Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2025-07-18Phase 3b, Single Arm, Single Site Simplification Study of HIV-1 Infected Patients With Virological Suppression Under the Combination of Lamivudine (150 mg BID) Plus Raltegravir (400 mg BID) Switching to Lamivudine (300 mg QD) Plus Raltegravir (1200 mg QD) : Roll-over Study of the RALAM Clinical Trial (NCT02284035)
-
CLINICAL_TRIALS study record update · 2025-07-16A Limited-Center, Prospective, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Cenicriviroc Mesylate on Arterial Inflammation in People Living With HIV
-
CLINICAL_TRIALS study record update · 2025-07-04A Phase 1 Open-label Clinical Trial to Evaluate the Safety and Immunogenicity of Synthetic DNAs Encoding a Native-like HIV Env Trimer and Interleukin-12 (INO-6160), Alone or in a Prime-boost Regimen With 3M-052-AF + Alum Adjuvanted VRC HIV Env Trimer 4571 in Adult Participants Without HIV
-
CLINICAL_TRIALS study record update · 2025-06-25Clinical Trial Phase II, Multicenter, Open-label, Randomized and Controlled Trial to Eliminate the Latent Reservoir of HIV-1 by Administering High Doses of Antiretroviral Drugs.
-
CLINICAL_TRIALS study record update · 2025-06-11MODULO Trial: Doravirine/Lamivudine (DOR/3TC) as a Maintenance ART in Comparison With Dolutegravir/Lamivudine (DTG/3TC) in PLWH Successfully Treated With Three-drug Regimens at Inclusion
-
CLINICAL_TRIALS study record update · 2025-06-05PET Imaging of Radiolabeled Anti-HIV-1 Envelope Monoclonal Antibody (VRC01)
-
CLINICAL_TRIALS study record update · 2025-06-04An Open-label Study Evaluating the Pharmacokinetics (PK), Efficacy, Safety, and Tolerability of CABENUVA (Long-acting Cabotegravir Plus Long-acting Rilpivirine) Intramuscular (IM) Administered Monthly and Every 2 Months in Virologically Suppressed HIV-1-Infected Adults With Severe Renal Impairment With or Without Hemodialysis (CAPRI)